Investors Flock to Startups Reprogramming Cell Therapies
Painstaking and expensive procedures are required to produce human cells for use in research and…
Painstaking and expensive procedures are required to produce human cells for use in research and…
Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science…
Despite vast amounts of funding entering the cell and gene therapy field, the manufacture of…
Confidence in gene-edited T cell therapies from donor cells has faltered as Allogene Therapeutics paused…
For cell therapy to become mainstream, important issues such as management of risk and quality…
This week’s €64M Series B fundraise from the French firm TreeFrog Therapeutics is the latest…
From red blood cells to platelets, the cells in our own blood could prove an…
Swedish firm Anocca's fundraising is the first major venture capital round to go to a…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
Searching for the fountain of eternal youth has been the dream of humanity for millennia.…
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood…